Burning Rock Biotech Limited
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $77.2M | $70.7M | $75.7M | $81.7M | $79.7M | $65.9M |
| Cost of Revenue | $19.5M | $21.0M | $24.5M | $26.6M | $22.6M | $17.8M |
| Gross Profit | $57.6M | $49.6M | $51.2M | $55.1M | $57.1M | $48.1M |
| Gross Margin | 74.7% | 70.3% | 67.6% | 67.5% | 71.7% | 73.0% |
| Operating Expenses | ||||||
| Research & Development | $23.8M | $31.8M | $48.9M | $61.2M | $57.7M | $40.5M |
| SG&A Expense | $18.0M | $35.8M | $61.7M | $82.4M | $76.9M | $45.0M |
| Operating Income | $-7.8M | $-49.0M | $-94.3M | $-142.1M | $-125.1M | $-63.2M |
| Operating Margin | -10.2% | -69.3% | -124.5% | -174.1% | -156.9% | -95.9% |
| Interest Expense | — | — | — | — | $241.0K | $102.0K |
| Pretax Income | $-7.7M | $-46.7M | $-91.7M | $-140.5M | $-124.9M | $-62.4M |
| Income Tax Expense | $223.0K | $806.0K | $336.0K | $288.0K | $141.0K | $0 |
| Net Income | $-7.9M | $-47.5M | $-92.1M | $-140.8M | $-125.0M | $-62.4M |
| Net Margin | -10.3% | -67.2% | -121.6% | -172.4% | -156.9% | -94.7% |
| EPS (Basic) | — | — | — | — | $0.00 | $0.00 |
| EPS (Diluted) | — | — | — | — | $0.00 | $0.00 |
| Shares Outstanding (Basic) | — | — | — | — | — | 0 |
| Shares Outstanding (Diluted) | — | — | — | — | — | 0 |
| Dividends Per Share | — | — | — | — | — | — |